Carrera Bioscience Inc.

Medtech · Private

LAMP-based point-of-care diagnostic assays for simultaneous detection of all five hepatitis viruses, integrated with a handheld fluorescence detection instrument and no-power sample preparation

Grants
$1.1M
4 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$1.0M
4 awards · Health and Human S, Defense
#317 of 4531 in medtech
Patents
2
0 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Defense · Phase I · Biomimetic Material Solutions for the Stabilization of Labile Reagents$150,000
Federal grantDepartment of Defense · Phase I · Concurrent identification of Natural Antibiotics-Producing Gene Clusters and Culture Conditions$149,993
Federal contractDepartment of Health and Human Services · Igf::ct::igf For Critical Functions$150,000
Federal contractDepartment of Defense · Igf::ot::igf C152-004-0127 SBIR Phase I$99,999
Federal contractDepartment of Health and Human Services · Igf::ct::igf For Critical Functions$149,999
Federal contractDepartment of Health and Human Services · SBIR Phase II Igf::ot::igf$604,500
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
314VOX BIOMEDICAL LLC$1.0M—
315CREATV MICROTECH INC$1.0M—
316inNOveta Biomedical LLC$1.0M—
317Carrera Bioscience Inc.$1.0M—
318BIOWAVE CORP$1.0M$1.7M
319ZETROZ SYSTEMS LLC$1000K—
320Caregility Corp$997K$7.5M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 2
  • Virus-specific Diagnosis Of Hepatitis Infection Using Isothermal Amplification In Resource-poor Settingsapplication
  • Multiplex Enteric Assay And Methods Of Use Thereofapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.